Pharma Journalist -

On having received $ 38 million Series A financing by Maxim Merchant Capital, Alveo technologies to embark on curation of efficient and cost-effective disease diagnostic devices aiding…
Read More...

Shanghai Sinobioway Sunterra Biotechnology (SSSB) and F1 oncology initiate new development, manufacturing, and supply to finish a new cGMP manufacturing facility in Shenzhen with the…
Read More...

Takeda Pharmaceuticals and Denali therapeutics asserted that they have collaborated to develop and commercialize up to three specified therapeutic product candidates for…
Read More...

Celgene and Impact biomedicines signed an agreement that enumerates acquisition of Impact Biomedicines by Celgene to develop fedratinib for myelofibrosis and Polycythemia Vera. As per…
Read More...

A generic pharmaceutical company Leading Pharma, LLC that manufactures and distributes drug chains, wholesalers declared that it became a successful recipient of $ 40 million of growth…
Read More...

Semnur Pharmaceuticals announced the commencement of phase 3 clinical trials in the U.S to evaluate its product SP-102 in patients suffering from lumbar radicular pain/sciatica. It is…
Read More...

Biopharmaceutical company Kala pharmaceuticals into development and commercialization of product candidates incorporating the usage of MPP technology declared that the New drug…
Read More...

A Shanghai-based integrated biopharmaceutical company, Jiangsu Hengrui Medicine and Arcutis, a Menlo Park, CA-based Biotechnology Company declared licensing agreement to commercialize…
Read More...

Harbour BioMed declared that it ventures into licensing agreement with BeiGene for producing human therapeutic monoclonal antibodies to a commercial-stage biopharmaceutical company that…
Read More...

SMi Group reports: If you are involved in paediatric clinical trials then SMi Groups Paediatric Clinical Trials conference, is a must attend event…and here is why… If you are looking…
Read More...